Tumor response in the CLARINET study of lanreotide depot vs. placebo in patients with metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs).

被引：9
|
作者：
Phan, Alexandria T.
Dasari, Arvind
Liyanage, Nilani
Cox, David
Lowenthal, Susan Pitman
Wolin, Edward M.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Ipsen Biopharmaceut Inc, Boulogne, France
[3] Ipsen Biopharmaceut Inc, Basking Ridge, NJ USA
[4] Univ Kentucky, Markey Canc Ctr, Lexington, KY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 04期
关键词：
D O I：
10.1200/jco.2016.34.4_suppl.434
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
434
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Tumor Response in the CLARINET Study of Lanreotide Depot/Autogel vs Placebo in Patients With Metastatic Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)
    不详
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (03) : 11 - 12
  • [2] RESPONSE RATES IN THE PHASE 3 CLARINET TRIAL OF LANREOTIDE DEPOT VS PLACEBO IN PATIENTS WITH METASTATIC GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS (GEP-NETS).
    Iwasaki, Michiko
    Wolin, Edward
    Dasari, Arvind
    Liyanage, Nilani
    Lowenthal, Susan Pitman
    Phan, Alexandria
    [J]. ONCOLOGY NURSING FORUM, 2016, 43 (02) : 136 - 136
  • [3] Gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
    Kizilgul, Muhammed
    Delibasi, Tuncay
    [J]. TRANSLATIONAL GASTROINTESTINAL CANCER, 2015, 4 (01) : 39 - 56
  • [4] Lanreotide vs. Octreotide-LAR for Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs): An Observational Time and Motion Analysis
    Ryan, Pamela
    McBride, Ali
    Ray, David
    Pulgar, Sonia
    Ramirez, Robert
    Elquza, Emad
    Favaro, Justin
    Dranitsaris, George
    [J]. PANCREAS, 2019, 48 (03) : 450 - 450
  • [5] The CLARINET Study - Assessing the Effect of Lanreotide Autogel on Tumor Progression-Free Survival in Patients with Non-Functioning Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)
    Joelle, Blumberg
    Nilani, Liyanage
    Martyn, Caplin
    [J]. PANCREAS, 2012, 41 (02) : 343 - 343
  • [6] Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) Preface
    de Herder, Wouter W.
    [J]. BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2012, 26 (06) : 689 - 690
  • [7] Cutaneous Metastasis of Gastroenteropancreatic Neuroendocrine Tumors (GEP-Nets)
    Dhingra, Rohit
    Tse, Julie Y.
    Saif, Muhammad Wasif
    [J]. JOURNAL OF THE PANCREAS, 2018, 19 (05): : 258 - 260
  • [8] Predictive Markers of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETS)
    Issaeva, S.
    Khalimova, Z.
    Safarova, M.
    Gumarova, A.
    Yuldashev, A.
    [J]. NEUROENDOCRINOLOGY, 2018, 106 : 89 - 89
  • [9] mTOR Pathway in Gastroenteropancreatic Neuroendocrine Tumor (GEP-NETs)
    Zanini, Sara
    Renzi, Serena
    Giovinazzo, Francesco
    Bermano, Giovanna
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2020, 11
  • [10] PROGNOSTIC FACTORS INFLUENCING GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS (GEP-NETs)
    Arrazubi, Virginia
    Sala, Marian
    Galve, Elena
    Teresa Perez-Hoyos, Maria
    Hinojo, Carmen
    Etxezarraga, Carmen
    Gonzalez, Carmen
    Gomez, Pilar
    Martinez del Prado, Purificacion
    [J]. ANNALS OF ONCOLOGY, 2011, 22 : v69 - v69
12345